BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT01609556-completion@plaintrial.com
DTSTAMP:20261028T012852Z
DTSTART;VALUE=DATE:20180319
SUMMARY:First-in-Human Study to Evaluate the Safety\, Tolerability\, Pharma
 cokinetics and Pharmacodynamics of Mirvetuximab Soravtansine in Adults Wit
 h Ovarian Cancer and Other Folate Receptor 1 (FOLR1)-Positive Solid Tumors
  — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT01609556
URL:https://plaintrial.com/trial/NCT01609556
END:VEVENT
END:VCALENDAR